jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Review

Exploring targeted pulmonary delivery for treatment of lung cancer

Amit Goel1★, Sanjula Baboota1, Jasjeet K Sahni1, Javed Ali1★ Corresponding author

  1. 1Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard University, New Delhi, INDIA.

CORRESPONDENCE

Amit Goel

Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard University, New Delhi, INDIA.

amitgoel16987@gmail.com

Volume 3, Issue 1 · pp. 8–14 · PUBLISHED 1 January 2013 · DOI: 10.4103/2230-973X.108959

View on IJPI original site ↗

ABSTRACT

Lung cancer is the most malignant cancer today. The treatment of lung cancer continues to be a challenge for oncologists. The direct delivery of chemotherapeutic agents to the lungs could represent a novel therapeutic approach for patients with pulmonary metastases. The large alveolar surface area, the low thickness of the epithelial barrier, and an extensive vascularization make the pulmonary route an ideal route for administration of oncolytics. This paper reviews the research performed over the last and current decades on the delivery of various oncolytics for pulmonary delivery for the treatment of lung cancer. Inhaled drug delivery devices in cancer therapy are also discussed in the present manuscript.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Goel, A., Baboota, S., Sahni, J. K., & Ali, J. (2013). Exploring targeted pulmonary delivery for treatment of lung cancer. International Journal of Pharmaceutical Investigation, 3(1), 8–14. https://doi.org/10.4103/2230-973X.108959